As of March 20, 2020, nine companies have had Covid-19 diagnostic tests authorized by the U.S. FDA. This statistic shows the FDA emergency use authorisations for Covid-19 tests (excluding academic-developed tests) as of 20 March, 2020, by 1-day share price move. After GenMark Diagnostics got an emergency use authorization (EUA) on March 19, its share price increased 41 percent over one day.
FDA emergency use authorizations for Covid-19 tests as of 20 March, 2020, by company 1-day share price move*
Company (date of emergency use authorisaztion, test name)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Vantage. (March 20, 2020). FDA emergency use authorizations for Covid-19 tests as of 20 March, 2020, by company 1-day share price move* [Graph]. In Statista. Retrieved November 18, 2024, from https://www.statista.com/statistics/1106499/fda-covid19-tests-by-company-share-price-move/
Vantage. "FDA emergency use authorizations for Covid-19 tests as of 20 March, 2020, by company 1-day share price move*." Chart. March 20, 2020. Statista. Accessed November 18, 2024. https://www.statista.com/statistics/1106499/fda-covid19-tests-by-company-share-price-move/
Vantage. (2020). FDA emergency use authorizations for Covid-19 tests as of 20 March, 2020, by company 1-day share price move*. Statista. Statista Inc.. Accessed: November 18, 2024. https://www.statista.com/statistics/1106499/fda-covid19-tests-by-company-share-price-move/
Vantage. "Fda Emergency Use Authorizations for Covid-19 Tests as of 20 March, 2020, by Company 1-day Share Price Move*." Statista, Statista Inc., 20 Mar 2020, https://www.statista.com/statistics/1106499/fda-covid19-tests-by-company-share-price-move/
Vantage, FDA emergency use authorizations for Covid-19 tests as of 20 March, 2020, by company 1-day share price move* Statista, https://www.statista.com/statistics/1106499/fda-covid19-tests-by-company-share-price-move/ (last visited November 18, 2024)
FDA emergency use authorizations for Covid-19 tests as of 20 March, 2020, by company 1-day share price move* [Graph], Vantage, March 20, 2020. [Online]. Available: https://www.statista.com/statistics/1106499/fda-covid19-tests-by-company-share-price-move/
